Corvus Pharmaceuticals (CRVS) SEC Filings & 10K Form

$1.69
+0.08 (+4.97%)
(As of 09:02 AM ET)

Recent Corvus Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/01/2024
4:06 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2024
4:57 PM
Arcara Jeffrey (Reporting)
Corvus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
12:31 PM
Corvus Pharmaceuticals (Subject)
SAMLYN CAPITAL, LLC (Filed by)
Form SC 13G
02/13/2024
5:27 PM
Corvus Pharmaceuticals (Subject)
MILLER RICHARD A MD (Filed by)
Form SC 13G/A
09/06/2023
6:39 PM
Corvus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2023
4:03 PM
Corvus Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2023
3:54 PM
Corvus Pharmaceuticals (Issuer)
Grais Linda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2023
11:15 PM
Corvus Pharmaceuticals (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CRVS) was last updated on 5/2/2024 by MarketBeat.com Staff

From Our Partners